Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Submits Application for Research License to Health Canada
Lexaria has developed its DehydraTECH technology The company also has four new subsidiaries Lexaria recently submitted its application to Health Canada for a research license Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a research-driven company that has developed and out-licenses its DehydraTECH technology – a drug delivery platform. It is the only company globally with a patent issued for oral delivery of all cannabinoids. The company’s technology facilitates the delivery of bioactive substances via oral ingestion without the need for inhalational dosing or co-administration with sugars or sweeteners. Lexaria Bioscience is headquartered in Kelowna, British Columbia. Lexaria has four…
